Business
Utah to seek curbs on delta-8 THC, other synthetics in medical marijuana market
Utah regulators say they’re pushing for new rules governing the presence of delta-8 THC and other synthetic cannabinoids allowed in the state’s medical marijuana supply.
The regulators are reacting after patient advocates, product makers and researchers sounded the alarm over safety concerns in an MMJ market that Utah voters legalized in 2018.
The first medical cannabis pharmacies – as MMJ dispensaries are called in Utah – opened in 2020 after the state Legislature and then-Republican Gov. Gary Hebert made later tweaks.
Those tweaks make Utah an outlier among its more liberal neighbors such as Colorado and Nevada, according to patient advocates and researchers.
Unlike those two states, Utah law currently allows “THC analogs” into edibles, vaporizer cartridges and other products sold in state-licensed pharmacies.
Analogs are defined as “a substance that is structurally or pharmacologically similar to, or is represented as being similar to, delta-9-THC.”
State officials admit this has made it legal for MMJ pharmacies to sell products that contain delta-8 THC as well as other controversial synthetic derivatives with unknown safety profiles, including delta-6 and delta-10 THC.
Underscoring concerns from researchers and advocates, Utah patients have reported adverse effects such as blackouts after using products containing delta-8 THC, which other states have banned.
Largely unknown to the public before passage of the 2018 Farm Bill – which triggered a flood of hemp and hemp-derived products nationwide – delta-8 THC can be created from CBD isolate via a chemical process.
That process is almost entirely unregulated.
Experts have said that the chemical process might also taint the end product with contaminants that are unknown to science and not detected during laboratory analysis.
Authorities also blamed delta-8 THC for the May death of a Virginia toddler, whose mother was charged with homicide.
Although, to date, “no public health body has recognized a synthetic cannabinoid as a toxic or deleterious substance,” the Utah Department of Agriculture and Food (UDAF) is asking for changes to state law “that would allow us to restrict the presence of synthetic cannabinoids in products in Utah, even if they have not been demonstrated to be toxic,” said Brandon Forsyth, the director of the agency’s Cannabis and Hemp Division.
“This is being done out of an abundance of caution,” Forsyth told MJBizDaily via email.
Whether the changes would impose limits or an outright ban is “still being discussed,” he added.
“As I’m sure you can appreciate, there are a lot of details to consider.”
‘Hot-button deal’
The UDAF’s pivot to consider new rules follows a monthslong public-safety campaign led by marijuana manufacturers and patients, some of whom say that products containing delta-8 THC purchased at state-licensed MMJ pharmacies caused troubling complications.
Other critics have said that Utah’s allowances for delta-8 THC and other analogs allows so-called “hot hemp” into the state medical cannabis program, charges regulators have denied.
“This is a super-hot-button deal,” said Blake Smith, a trained biochemist and chief scientific officer at Zion Medicinal, a licensed manufacturer in Salt Lake City that makes oils and other products sold at MMJ pharmacies across the state.
Smith expressed familiar concerns over these understudied analogs’ unknown safety profiles.
He and other advocates have called for state authorities to more strictly regulate Utah MMJ products – and, if necessary, ban analogs outright.
“Here’s the deal: Lack of data does not equal safety,” he said. “If we don’t know anything about these things that we just discovered, we should probably not be giving them to cancer patients.
“I think that’s perfectly reasonable, and yet, nobody seems to be moving in that direction.”
Alex Iorg is the co-founder of Salt Lake City-based WholesomeCo Cannabis, which sells products such as vaporizer cartridges that contain delta-6 and delta-10 THC, according to the company’s website.
That disclosure is a recent development, an update made “to improve transparency of the presence of these cannabinoids,” Iorg said.
“In the end, we rely on and comply with the state’s guidance on testing requirements and patient safety,” he said, noting that “a lot is unknown about these cannabinoids.”
He also questioned whether other states might also have synthetic cannabinoids in their regulated medical cannabis products supplies.
“State regulators suggested this may not just be a Utah issue but, rather, a national cannabis issue,” he said.
“We are curious to find this out as well, as Utah’s cannabis production standards and practices did not originate in Utah.”
In a Nov. 3 news release, the UDAF acknowledged “recent increases in the availability of products that contain poorly characterized cannabinoids,” including “cannabinoids that are produced semi-synthetically/synthetically,” such as delta-8.
The department pulled some products from shelves over safety concerns, but those holds were lifted by the state Department of Health and Human Services (DHHS) – which directly oversees the Utah medical cannabis program – after the agency was “unable to find any evidence that these cannabinoids are harmful to human health at this time,” according to the UDAF.
OK, as long as it’s labeled
That release followed an Oct. 25 hearing in which Rich Oborn, director of the DHHS’ Center for Medical Cannabis, confirmed that Utah allows “synthetic and derivative cannabinoids,” provided they “are listed on cannabis product labels.”
Patients concerned about the safety of such products “should talk with their medical provider and/or a medical cannabis pharmacist to determine if they should use products with synthetic and derivative cannabinoids,” he added, according to meeting minutes and a recording.
The DHHS did not immediately respond to an MJBizDaily request for comment.
State lawmakers are expected to revisit medical marijuana regulations during the legislative session that begins in February.
That isn’t nearly enough for Zion Medicinal’s Smith and for outside observers such as Dr. Ethan Russo, a neurologist and acknowledged national expert.
In a letter he submitted to state authorities and shared with MJBizDaily, Russo pointed out that “it is possible to make a blanket assertion that all products with delta-8-THC content of significant concentrations are contaminated with delta-6-, delta-10-THC, possibly other isomers, and residual solvents, making them public health risks.”
Since “no formal studies” into these analogs’ toxicology and effects in humans have been conducted, these products should be pulled from shelves and not sold until they are studied, he said.
Blackouts, lack of trust
During that Oct. 25 meeting, several patients told state regulators that they suffered blackouts and other serious aftereffects after using state-licensed products that contained delta-8 THC and that the synthetics pose serious concerns.
Before making a recent purchase, “I had an hourlong conversation with a pharmacist, expressing I needed good, clean medicine,” medical marijuana patient Mitchell Butterfield said.
That pharmacist led him to purchase a vaporizer cartridge that indicated it contained delta-8 THC, he said.
“I asked him what was in it, and he said, ‘It’s still just THC. The state just makes it label it that way,’” Butterfield said.
He bought it and brought it home. He hit it and, “after five minutes, I started yawning uncontrollably and then I blacked out,” he said.
“In 50 years’ experience with this plant, I have never had an experience like that,” said Butterfield, who added that the MMJ pharmacy refused to give him a refund and instead offered him only half off a future purchase.
“I don’t trust the CBD products on the market because of all the synthetics. … The delta-9 and -6 and all of that garbage,” Emily Tucker, a patient who said she has a teenaged son who wants to treat anxiety with CBD but is fearful about product quality, said during the meeting with regulators.
“I want to keep him safe. I don’t want him to get high because people are trying to make a cheap high.”
Christine Stenquist, the founder and president of nonprofit advocacy group Together for Responsible Use and Cannabis Education (TRUCE), said the only acceptable level of THC analogs “is zero.”
“If you can’t create quality products, you should not have a license in this state,” she told MJBizDaily.
While she welcomes limits on synthetics, she faulted state regulators for trying to “minimize safety concerns from the beginning” and says she’s heard rumors that synthetic analogs will still be allowed under new legislation, though with age limits.
“We never wanted synthetics in the program,” she said. “They’re only acting out of abundance of caution because I am raising Cain everywhere.”
Source: https://mjbizdaily.com/utah-medical-marijuana-market-curbs-on-delta-8-thc-other-synthetics/
Business
Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light
Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).
The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.
India’s Indigenous LEO Satellite Vision
Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.
The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.
According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.
The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.
Regulatory Process Moves Forward
Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.
The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.
Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.
Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.
Broadband, Mobile Connectivity, and Strategic Applications
Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.
The company also intends to establish 20 to 22 ground stations across India to support network operations.
Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.
Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.
Major Step for India’s Space and Telecom Sectors
Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.
The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
